John M. Whitelock

The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases

John M. Whitelock, Alan D. Murdoch, Renato V. Iozzo et al. · Journal of Biological Chemistry · 1996 · 589 citations · Full text

Medicine, Cell Biology, Pathology +15

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

Claire Vennin, Pauline Mélénec, Romain Rouet et al. · Nature Communications · 2019 · 261 citations · Full text

Medicine, Cancer Biology, Oncology +17

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.

Bela Sharma, Melissa Handler, Inge Eichstetter et al. · Journal of Clinical Investigation · 1998 · 191 citations · Full text

Medicine, Cancer Biology, Oncology +17

Not All Perlecans Are Created Equal

Sarah M. Knox, Catherine L.R. Merry, Sally E. Stringer et al. · Journal of Biological Chemistry · 2002 · 155 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis

Vaishali Patel, Sarah M. Knox, Karen M. Likar et al. · Development · 2007 · 155 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17